In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: L'Oreal, S.A.

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal, S.A.: The Paris-based cosmetics company reported year- end sales grew 14.5% to $11.5 bil. (FFr 69.1 bil.). On a comparable basis using identical group structure and exchange rates, consolidated group sales increased 8.4%, with an 8.6% increase for cosmetics. In an ad in the Jan. 29 Wall Street Journal posting the results, L'Oreal suggests parties interested in the results "consult [a] bank, stockbroker or financial institution," or the firm's Web site (http://loreal-finance.com) for more information...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005073

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel